You are here

bone cancer

Bristol Myers pays $100M for a different kind of ADC

BioPharma Dive

Mon, 11/6/23 - 09:54 am

Bristol Myers Squibb

antibody-drug conjugate

Orum Therapeutics

Sierra Oncology records success in late-stage study of bone cancer drug

BioPharma Dive

Tue, 01/25/22 - 10:47 am

Sierra Oncology

clinical trials

This little cancer drug didn’t make it to market

Stat

Sat, 01/9/16 - 10:44 am

Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib

Wall Street Cheat Street

Sun, 02/3/13 - 11:59 am

Infinity Pharmaceuticals stock plunges after company stops potential cancer treatment study

Yahoo/AP

Mon, 06/18/12 - 10:56 am

Infinity Pharmaceuticals

Preliminary Data Demonstrate that 40 mg Daily Dose of Cabozantinib Yields a High Rate of Bone Scan Response in mCRPC

Yahoo/BusinessWire

Sun, 11/13/11 - 12:06 pm

prostate cancer

Amgen drug gets priority review for bone cancer

Marketwatch

Sun, 07/18/10 - 07:46 am